Alantos Initiates Phase I Clinical Trials With Lead Compound For Type II Diabetes

... Alantos Pharmaceuticals, a privately held biopharmaceutical company based on the discovery and development of small molecule drugs with a focus on type II diabetes and Osteoarthritis / inflammation, today announced that it has initiated a Phase 1 clinical study with its first clinical candidate, AL [click link for full article] ...